Perkins Capital Management Inc Abbott Laboratories Transaction History

Perkins Capital Management Inc

$102 Million
Q3 2024

A detailed history of Perkins Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Perkins Capital Management Inc holds 22,830 shares of ABT stock, worth $2.72 Million. This represents 2.56% of its overall portfolio holdings.

Number of Shares

22,830

Previous 24,880 8.24%

Holding current value

$2.72 Million

Previous $2.59 Million 0.66%

% of portfolio

2.56%

Previous 2.55%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$100.07 - $118.13 $205,143 - $242,166	-2,050 Reduced 8.24%	22,830 $2.6 Million
Q2 2024 Aug 09, 2024	SELL	$100.73 - $112.44 $50,365 - $56,220	-500 Reduced 1.97%	24,880 $2.59 Million
Q2 2023 Jul 21, 2023	SELL	$100.78 - $112.29 $100,780 - $112,290	-1,000 Reduced 3.79%	25,380 $2.77 Million
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $9,686 - $11,401	-100 Reduced 0.38%	26,380 $2.67 Million
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $47,530 - $55,760	-500 Reduced 1.85%	26,480 $2.91 Million
Q3 2022 Oct 24, 2022	SELL	$96.76 - $112.03 $9,676 - $11,203	-100 Reduced 0.37%	26,980 $2.61 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $57,765 - $70,730	-500 Reduced 1.81%	27,080 $3.81 Million
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $47,250 - $51,489	-450 Reduced 1.61%	27,580 $3.02 Million
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $19,519 - $23,704	-213 Reduced 0.75%	28,030 $3.05 Million
Q1 2020 Apr 29, 2020	SELL	$62.82 - $91.86 $3,141 - $4,593	-50 Reduced 0.18%	28,243 $2.23 Million
Q4 2019 Feb 03, 2020	SELL	$78.51 - $87.4 $496,026 - $552,193	-6,318 Reduced 18.25%	28,293 $2.46 Million
Q3 2019 Oct 23, 2019	SELL	$81.84 - $88.74 $85,932 - $93,177	-1,050 Reduced 2.94%	34,611 $2.9 Million
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $254,569 - $296,905	-3,493 Reduced 8.92%	35,661 $3 Million
Q1 2019 Apr 22, 2019	SELL	$66.22 - $80.06 $2.5 Million - $3.02 Million	-37,746 Reduced 49.08%	39,154 $3.13 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $9,834 - $11,140	-150 Reduced 0.19%	76,900 $5.56 Million
Q2 2018 Aug 02, 2018	SELL	$57.57 - $63.54 $224,523 - $247,806	-3,900 Reduced 4.82%	77,050 $4.7 Million
Q4 2017 Jan 26, 2018	SELL	$53.68 - $57.47 $113,264 - $121,261	-2,110 Reduced 2.54%	80,950 $4.62 Million
Q3 2017 Oct 31, 2017	BUY	$48.06 - $53.64 $3.99 Million - $4.46 Million	83,060	83,060 $4.43 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.

Account

Perkins Capital Management Inc Abbott Laboratories Transaction History